{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT04038255",
            "orgStudyIdInfo": {
                "id": "20190328"
            },
            "organization": {
                "fullName": "University of Miami",
                "class": "OTHER"
            },
            "briefTitle": "Mindfulness Based Smoking Cessation Among Cancer Survivors",
            "officialTitle": "Smartphone Application Versus Group Mindfulness-based Smoking Cessation Intervention for Cancer Patients and Survivors: Reach Versus Effectiveness",
            "therapeuticArea": [
                "Other"
            ],
            "study": "mindfulness-based-smoking-cessation-among-cancer-survivors"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2019-09-28",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-09",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-09",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2019-07-26",
            "studyFirstSubmitQcDate": "2019-07-26",
            "studyFirstPostDateStruct": {
                "date": "2019-07-30",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-07",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-09",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Taghrid Asfar",
                "investigatorTitle": "Research Assistant Professor",
                "investigatorAffiliation": "University of Miami"
            },
            "leadSponsor": {
                "name": "University of Miami",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This study will examine the effect of a mindfulness-based smoking cessation program among cancer survivors."
        },
        "conditionsModule": {
            "conditions": [
                "Tobacco Smoking"
            ],
            "keywords": [
                "cancer",
                "nicotine replacement therapy",
                "mindfulness"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE4"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 30,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Usual Care",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "Participants in this group will receive a brief advice to quit smoking, 6-week supplies of nicotine replacement therapy (NRT), and self-help materials to quit smoking.",
                    "interventionNames": [
                        "Drug: Nicoderm C-Q Transdermal Product",
                        "Behavioral: Brief advice on quitting smoking",
                        "Behavioral: Self-help smoking cessation materials"
                    ]
                },
                {
                    "label": "Craving-to-Quit app",
                    "type": "EXPERIMENTAL",
                    "description": "Participants in this group will receive one \"in-person\" or online orientation session, 6-week supply of NRT, the \"Craving-to-Quit\" app, and two brief follow-up phone calls.",
                    "interventionNames": [
                        "Drug: Nicoderm C-Q Transdermal Product",
                        "Behavioral: Orientation session",
                        "Behavioral: Craving-to-Quit app",
                        "Behavioral: Two brief follow-up phone calls"
                    ]
                },
                {
                    "label": "Group Mindfulness Training",
                    "type": "EXPERIMENTAL",
                    "description": "Participants in this group will receive twice weekly group sessions (eight total during 4 weeks) that were manualized and delivered by instructors experienced in Mindfulness Training (MT) (a single therapist with \\>4 years of training in MT).",
                    "interventionNames": [
                        "Drug: Nicoderm C-Q Transdermal Product",
                        "Behavioral: Orientation session",
                        "Behavioral: Group MT sessions"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Nicoderm C-Q Transdermal Product",
                    "description": "6 weeks of nicotine replacement therapy patches",
                    "armGroupLabels": [
                        "Craving-to-Quit app",
                        "Group Mindfulness Training",
                        "Usual Care"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Orientation session",
                    "description": "This session will occur 2 weeks before quit date. It will be moderated by a certified instructor in MT, and will last approximately 90 min. During the session, participants will learn the purpose, format, and procedures of the study, provide electronic informed consent which will be audio-recorded with their permission, and complete the baseline assessment.",
                    "armGroupLabels": [
                        "Craving-to-Quit app",
                        "Group Mindfulness Training"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Craving-to-Quit app",
                    "description": "The app is comprised of 22 modules for 22 days, 5-15 minutes each, designed to teach MT using audio, video, and animation. The app also includes other features such as social support (quit friend sign-ups, the tip of the week), activity feed (to track interaction with the app), and my morning stats (to track smoking).",
                    "armGroupLabels": [
                        "Craving-to-Quit app"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Two brief follow-up phone calls",
                    "description": "The first phone call will occur one day before the quit date to remind participants about their quit date and provide support. The second will occur at the end of treatment (around day 60 after quit date) to review progress, provide support, and schedule the 3-month follow-up visit. Each phone call will last approximately 15 minutes.",
                    "armGroupLabels": [
                        "Craving-to-Quit app"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Group MT sessions",
                    "description": "Total of eight group sessions (twice a week) during 4 weeks. The overarching theme of momentary awareness and acceptance of cravings and affect (e.g., stress, anxiety etc.) will be introduced and reinforced in complementary ways throughout the training. Each session will last 45-60 minutes.",
                    "armGroupLabels": [
                        "Group Mindfulness Training"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Brief advice on quitting smoking",
                    "description": "Standard advice on how to quit smoking.",
                    "armGroupLabels": [
                        "Usual Care"
                    ]
                },
                {
                    "type": "BEHAVIORAL",
                    "name": "Self-help smoking cessation materials",
                    "description": "Written materials on how to quit smoking including contact info for state tobacco quitline.",
                    "armGroupLabels": [
                        "Usual Care"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of participants with confirmed smoking abstinence",
                    "description": "self-report of not smoking in the past 7-days, not even a puff, confirmed by expired carbon monoxide (CO) level of \\< 10 ng/ml",
                    "timeFrame": "3 months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in number of cigarettes smoked per day",
                    "description": "Self-reported number of cigarettes smoked per day by each participant (Question is: On average, how many cigarettes do you smoke per day?)",
                    "timeFrame": "Baseline, 3 months"
                },
                {
                    "measure": "Number of participants with reported relapse",
                    "description": "Relapse is defined as smoking at least once/week on two consecutive weeks.",
                    "timeFrame": "3 months"
                },
                {
                    "measure": "Usability of the Craving-to-Quit app as assessed by the number of times participant logged in the app",
                    "description": "How usable participants found the app measured by the absolute number of times logged into the app.",
                    "timeFrame": "3 months"
                },
                {
                    "measure": "Usability of the Craving-to-Quit app as assessed by the number of days of completed app use",
                    "description": "How usable participants found the app measured by self-reported number of completed days for the app.",
                    "timeFrame": "3 months"
                },
                {
                    "measure": "Usability of the Craving-to-Quit app as assessed by the comfortability with the app",
                    "description": "How usable participants found the app measured by the comfortability of the app via questionnaire with scores ranging from 0-10 with the higher score indicating increased comfortability with the app.",
                    "timeFrame": "3 months"
                },
                {
                    "measure": "Acceptability",
                    "description": "Assessed by 3 items \"How satisfied were you with the intervention?\", \"How likely are you to recommend this intervention to a friend?\" and \"How useful was the intervention?\" Each question is scored from 0-10 with the higher score indicating increased acceptability.",
                    "timeFrame": "3 months"
                },
                {
                    "measure": "Feasibility of recruitment as assessed via enrollment rate",
                    "description": "A feasible recruitment is defined as an enrollment rate of 70% or higher.",
                    "timeFrame": "Baseline"
                },
                {
                    "measure": "Attrition",
                    "description": "Defined as the number of participants not having a final visit at the end of treatment, categories include mortality, withdrawal from the study, transfer to non-study clinics, loss to follow-up without identifiable cause.",
                    "timeFrame": "3 months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Be 18 years and older\n* Cancer survivors (based on the NCI definition - \"a person is considered to be a survivor from the time of diagnosis until the end of life\" National Cancer Institute Dictionary of Cancer Terms, 2014)\n* Cancer patients currently in active treatment\n* Have smoked \u2265 5 cigarettes/day in the past year\n* Be interested in making a quit attempt in the next 30 days\n* Own a smartphone (apple/android)\n* Read/speak English\n* Able to consent\n* Have no plans to move in the next 3 months\n* Are not pregnant or planning to be pregnant in the following 3 months\n\nExclusion Criteria:\n\n* Have contraindication to NRT (past month myocardial infarction, history of serious arrhythmias/or unstable angina pectoris, dermatological disorder)\n* Have cognitive/mental health impairment that inhibits mindfulness treatment\n* Are currently being treated for smoking cessation, alcoholism, or illicit drug use\n* Are adults unable to consent\n* Are individuals who are not yet adults\n* Are pregnant women\n* Are prisoners",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Taghrid Asfar, MD",
                    "role": "CONTACT",
                    "phone": "305-243-3826",
                    "email": "tasfar@miami.edu"
                },
                {
                    "name": "Lily Friedman",
                    "role": "CONTACT",
                    "phone": "609-647-5800",
                    "email": "lxf699@miami.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Taghrid Asfar, MD",
                    "affiliation": "University of Miami",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "University of Miami",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33136",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Lily Friedman, BS",
                            "role": "CONTACT",
                            "phone": "609-647-5800",
                            "email": "lxf699@miami.edu"
                        },
                        {
                            "name": "Taghrid Asfar, MD",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "St. Jude Children's Research Hospital",
                    "status": "RECRUITING",
                    "city": "Memphis",
                    "state": "Tennessee",
                    "zip": "38105",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Tara M Brinkman",
                            "role": "CONTACT",
                            "email": "tara.brinkman@stjude.org"
                        },
                        {
                            "name": "Ruth Eliason",
                            "role": "CONTACT",
                            "email": "ruth.eliason@stjude.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 35.14953,
                        "lon": -90.04898
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009538",
                    "term": "Nicotine"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005731",
                    "term": "Ganglionic Stimulants"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018722",
                    "term": "Nicotinic Agonists"
                },
                {
                    "id": "D000018679",
                    "term": "Cholinergic Agonists"
                },
                {
                    "id": "D000018678",
                    "term": "Cholinergic Agents"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12478",
                    "name": "Nicotine",
                    "asFound": "Therapeutic goal",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4029",
                    "name": "Central Nervous System Stimulants",
                    "relevance": "LOW"
                },
                {
                    "id": "M20796",
                    "name": "Nicotinic Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M20758",
                    "name": "Cholinergic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "CNSSti",
                    "name": "Central Nervous System Stimulants"
                }
            ]
        }
    },
    "hasResults": false
}